Table L3
Child Lifetime Asthma Prevalence and Weighted Number
by Age and State or Territory: BRFSS 2016
State
Age Group
Unweighted
Number
Prevalence
(Percent)
Standard
Error
95% CI *
(Percent)
Weighted
Number
95% CI *
Weighted Number
Total **
0-4
12,717
5.2
0.35
(4.5–5.9)
552,022
(476,920–627,123)
Total **
5-9
13,450
12.8
0.50
(11.8–13.8)
1,572,340
(1,444,086–1,700,593)
Total **
10-14
16,110
16.0
0.53
(15.0–17.1)
1,815,374
(1,689,595–1,941,153)
Total **
15-17
13,208
17.7
0.63
(16.5–19.0)
1,440,523
(1,330,395–1,550,651)
AZ
0-4
305
5.8
2.36
(2.6–12.6)
23,663
(3,934–43,393)
AZ
5-9
400
12.8
2.27
(9.0–17.9)
47,524
(30,015–65,034)
AZ
10-14
509
16.4
2.11
(12.7–21.0)
68,344
(49,985–86,702)
AZ
15-17
449
17.7
2.57
(13.2–23.3)
46,673
(32,146–61,201)
CA
0-4
594
4.6
1.07
(2.9–7.2)
71,907
(38,315–105,500)
CA
5-9
582
12.5
1.50
(9.9–15.8)
272,107
(205,111–339,104)
CA
10-14
650
17.6
1.87
(14.3–21.6)
304,239
(234,575–373,902)
CA
15-17
509
16.5
1.95
(13.0–20.7)
250,696
(187,551–313,841)
CT
0-4
351
8.2
1.90
(5.2–12.8)
14,585
(7,676–21,494)
CT
5-9
477
15.4
1.99
(11.9–19.8)
29,606
(21,600–37,612)
CT
10-14
603
21.0
2.10
(17.1–25.4)
34,745
(27,106–42,384)
CT
15-17
548
21.0
2.26
(17.0–25.8)
27,446
(20,992–33,900)
FL
0-4
1,334
6.4
1.15
(4.5–9.1)
46,891
(29,911–63,872)
FL
5-9
1,447
14.1
1.43
(11.5–17.1)
126,532
(100,419–152,645)
FL
10-14
1,602
14.6
1.68
(11.6–18.2)
132,678
(100,596–164,759)
FL
15-17
1,248
17.7
2.10
(14.0–22.2)
109,842
(81,705–137,978)
GA
0-4
145
3.9
1.71
(1.7–9.0)
22,604
(3,132–42,075)
GA
5-9
194
20.0
3.38
(14.2–27.5)
109,055
(69,441–148,669)
GA
10-14
244
16.5
2.87
(11.6–22.9)
77,476
(49,093–105,858)
GA
15-17
199
23.6
4.00
(16.7–32.3)
93,710
(57,428–129,992)
HI
0-4
369
6.0
1.38
(3.8–9.4)
3,421
(1,867–4,975)
HI
5-9
353
18.2
2.62
(13.6–23.9)
14,649
(10,091–19,208)
HI
10-14
413
21.0
2.52
(16.4–26.3)
14,664
(10,843–18,485)
HI
15-17
286
25.6
3.30
(19.7–32.6)
12,326
(8,767–15,886)
IL
0-4
178
4.1
1.66
(1.8–8.9)
27,598
(5,337–49,858)
IL
5-9
197
8.1
1.95
(5.0–12.8)
60,998
(31,749–90,248)
IL
10-14
275
18.9
2.74
(14.1–24.9)
134,654
(92,616–176,692)
IL
15-17
252
16.4
2.84
(11.6–22.7)
76,146
(48,128–104,163)
IN
0-4
362
6.3
1.53
(3.9–10.0)
23,797
(12,145–35,448)
IN
5-9
445
14.5
2.04
(10.9–19.0)
61,867
(43,639–80,096)
IN
10-14
595
16.3
1.88
(13.0–20.4)
52,643
(39,836–65,449)
IN
15-17
488
18.5
2.16
(14.6–23.1)
48,704
(36,499–60,910)
KS
0-4
576
5.7
1.18
(3.7–8.5)
8,398
(4,892–11,904)
KS
5-9
565
12.3
1.57
(9.6–15.8)
24,032
(17,738–30,325)
KS
10-14
691
15.5
1.60
(12.6–18.9)
26,027
(20,383–31,671)
KS
15-17
563
16.9
1.81
(13.6–20.7)
18,358
(14,279–22,437)
KY
0-4
444
6.1
1.47
(3.8–9.7)
14,622
(7,626–21,618)
KY
5-9
434
11.1
1.88
(8.0–15.4)
25,606
(16,822–34,391)
KY
10-14
529
15.2
2.05
(11.6–19.7)
38,874
(28,251–49,498)
KY
15-17
568
20.8
2.77
(15.8–26.7)
29,356
(20,609–38,104)
ME
0-4
365
5.5
1.83
(2.8–10.4)
3,214
(1,045–5,383)
ME
5-9
429
12.2
1.98
(8.9–16.7)
7,889
(5,297–10,482)
ME
10-14
545
17.8
2.40
(13.6–23.0)
10,821
(7,681–13,961)
ME
15-17
438
22.5
3.15
(16.9–29.3)
9,786
(6,706–12,865)
MA
0-4
122
4.1
2.34
(1.3–12.1)
10,123
(0–21,689)
MA
5-9
154
8.8
2.53
(4.9–15.2)
26,625
(11,297–41,952)
MA
10-14
177
21.5
4.20
(14.4–30.8)
71,543
(40,492–102,593)
MA
15-17
151
22.9
4.62
(15.1–33.2)
51,711
(28,734–74,687)
MI
0-4
525
5.6
1.22
(3.7–8.6)
28,933
(16,382–41,484)
MI
5-9
592
11.6
1.52
(8.9–14.9)
63,668
(46,533–80,803)
MI
10-14
689
15.5
1.51
(12.8–18.7)
76,647
(61,321–91,974)
MI
15-17
653
19.0
1.95
(15.4–23.1)
65,518
(51,085–79,951)
MN
0-4
759
3.2
0.81
(1.9–5.2)
6,729
(3,285–10,173)
MN
5-9
819
8.7
1.17
(6.7–11.3)
30,850
(22,410–39,290)
MN
10-14
911
15.0
1.41
(12.4–18.0)
43,278
(34,765–51,792)
MN
15-17
746
15.7
1.77
(12.6–19.5)
33,344
(25,312–41,377)
MS
0-4
250
6.0
1.82
(3.3–10.7)
10,253
(4,027–16,479)
MS
5-9
289
10.8
1.97
(7.5–15.3)
17,815
(11,262–24,368)
MS
10-14
276
15.5
2.95
(10.6–22.2)
25,765
(15,375–36,155)
MS
15-17
224
13.9
2.64
(9.5–19.9)
16,816
(10,253–23,380)
MO
0-4
252
6.1
1.59
(3.7–10.1)
18,618
(9,055–28,180)
MO
5-9
282
12.0
2.74
(7.6–18.5)
41,464
(21,669–61,259)
MO
10-14
367
15.6
2.68
(11.0–21.6)
51,749
(33,159–70,339)
MO
15-17
284
21.0
3.47
(15.0–28.6)
43,119
(27,041–59,198)
MT
0-4
296
3.2
1.38
(1.4–7.3)
1,572
(238–2,907)
MT
5-9
292
8.8
2.35
(5.1–14.6)
5,298
(2,433–8,164)
MT
10-14
333
11.1
2.52
(7.0–17.0)
5,899
(3,124–8,675)
MT
15-17
254
10.4
2.87
(5.9–17.5)
3,789
(1,638–5,939)
NE
0-4
862
3.6
1.00
(2.1–6.2)
3,799
(1,720–5,879)
NE
5-9
822
5.9
1.24
(3.9–8.9)
7,232
(4,171–10,293)
NE
10-14
921
12.8
1.54
(10.1–16.2)
15,795
(11,892–19,698)
NE
15-17
741
17.0
2.30
(12.9–22.0)
12,036
(8,532–15,540)
NV
0-4
183
3.5
1.75
(1.3–9.1)
5,473
(0–10,999)
NV
5-9
198
16.5
3.76
(10.4–25.2)
29,519
(15,298–43,739)
NV
10-14
223
14.8
3.57
(9.1–23.2)
17,898
(8,727–27,069)
NV
15-17
194
9.9
2.60
(5.8–16.3)
9,817
(4,657–14,976)
NJ
0-4
271
4.9
1.70
(2.5–9.5)
23,728
(7,308–40,147)
NJ
5-9
339
19.5
3.04
(14.2–26.2)
81,051
(53,748–108,354)
NJ
10-14
389
11.2
2.08
(7.7–16.0)
43,018
(26,701–59,334)
NJ
15-17
322
15.4
2.79
(10.7–21.7)
41,430
(25,909–56,951)
NM
0-4
247
9.4
2.72
(5.2–16.2)
12,495
(4,987–20,003)
NM
5-9
295
15.5
2.89
(10.6–22.0)
18,241
(10,994–25,488)
NM
10-14
366
19.3
2.77
(14.5–25.4)
19,410
(13,520–25,300)
NM
15-17
268
15.9
2.90
(11.0–22.4)
11,486
(7,129–15,843)
NY
0-4
504
4.8
1.75
(2.4–9.7)
43,786
(11,982–75,591)
NY
5-9
462
15.7
2.98
(10.7–22.5)
149,144
(89,877–208,411)
NY
10-14
587
14.0
2.22
(10.2–19.0)
134,399
(90,759–178,039)
NY
15-17
455
20.3
3.17
(14.7–27.2)
132,226
(88,448–176,004)
OH
0-4
446
5.3
1.35
(3.2–8.7)
30,848
(15,282–46,414)
OH
5-9
504
9.1
1.72
(6.2–13.0)
52,306
(32,084–72,528)
OH
10-14
640
15.7
1.94
(12.2–19.9)
91,822
(67,939–115,705)
OH
15-17
503
13.1
1.93
(9.7–17.3)
55,588
(38,889–72,288)
OK
0-4
276
3.9
1.17
(2.1–6.9)
8,107
(3,266–12,949)
OK
5-9
292
17.6
2.77
(12.8–23.7)
45,828
(30,283–61,372)
OK
10-14
322
19.0
2.54
(14.5–24.5)
41,654
(29,939–53,370)
OK
15-17
226
18.6
3.16
(13.2–25.6)
27,509
(17,386–37,632)
OR
0-4
249
3.5
1.61
(1.4–8.5)
6,098
(550–11,646)
OR
5-9
253
9.2
1.94
(6.1–13.8)
18,336
(10,694–25,978)
OR
10-14
268
16.6
2.57
(12.1–22.2)
36,978
(25,105–48,850)
OR
15-17
200
16.2
2.85
(11.3–22.6)
25,134
(16,071–34,196)
PA
0-4
334
7.3
1.81
(4.4–11.7)
39,148
(19,540–58,755)
PA
5-9
320
12.8
2.26
(9.0–18.0)
86,502
(55,045–117,960)
PA
10-14
352
14.9
2.30
(11.0–20.0)
96,467
(65,739–127,194)
PA
15-17
306
19.7
2.76
(14.8–25.6)
85,252
(60,079–110,426)
RI
0-4
203
2.9
1.42
(1.1–7.4)
1,553
(54–3,051)
RI
5-9
226
18.4
3.40
(12.6–26.0)
10,054
(6,070–14,039)
RI
10-14
342
17.0
2.67
(12.4–22.9)
6,979
(4,650–9,309)
RI
15-17
244
21.1
3.65
(14.9–29.2)
8,056
(4,922–11,189)
UT
0-4
766
1.8
0.53
(1.0–3.2)
3,368
(1,468–5,268)
UT
5-9
698
7.1
1.18
(5.1–9.8)
18,444
(12,294–24,593)
UT
10-14
905
13.9
1.46
(11.3–17.0)
29,386
(22,963–35,808)
UT
15-17
731
13.1
1.56
(10.3–16.4)
17,902
(13,513–22,292)
VT
0-4
286
11.7
3.10
(6.8–19.2)
3,078
(1,345–4,811)
VT
5-9
256
10.1
2.20
(6.5–15.3)
3,148
(1,777–4,519)
VT
10-14
348
14.2
2.30
(10.2–19.3)
4,019
(2,691–5,347)
VT
15-17
296
19.9
4.90
(11.9–31.2)
3,994
(1,719–6,269)
WA
0-4
636
5.7
1.26
(3.7–8.8)
18,833
(10,483–27,183)
WA
5-9
609
11.7
1.65
(8.9–15.4)
53,338
(37,838–68,838)
WA
10-14
782
12.6
1.44
(10.0–15.7)
49,918
(38,029–61,808)
WA
15-17
627
16.5
2.03
(12.9–20.8)
40,586
(29,815–51,358)
WI
0-4
227
5.7
2.24
(2.6–12.0)
14,778
(2,918–26,638)
WI
5-9
225
10.4
3.12
(5.6–18.3)
33,611
(12,460–54,762)
WI
10-14
256
17.5
3.50
(11.7–25.4)
57,584
(32,750–82,418)
WI
15-17
235
15.4
2.92
(10.5–22.0)
32,165
(19,471–44,859)
Territory
PR
0-4
251
22.1
4.08
(15.1–31.1)
44,469
(25,325–63,613)
PR
5-9
259
20.0
2.95
(14.8–26.4)
38,955
(27,607–50,302)
PR
10-14
300
30.8
3.65
(24.1–38.4)
56,572
(42,240–70,904)
PR
15-17
264
22.6
3.68
(16.2–30.6)
31,545
(20,264–42,826)
Notes:
* CI denotes confidence interval.
** Total includes data from 31 states based on cellphone and landline data combined excludes the territory,
Puerto Rico.
If values for the standard error and the 95% confidence interval are not provided, the normal approximation
to the binomial distribution does not apply due to small sample size.
When the sample size is less than 50, estimates are not precise and should be interpreted with caution.
Links with this icon indicate that you are leaving the CDC website.
The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
You will be subject to the destination website's privacy policy when you follow the link.
CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website.
For more information on CDC's web notification policies, see Website Disclaimers.